Literature DB >> 6508984

Tissue extraction of amiodarone and N-desethylamiodarone in man after a single oral dose.

A Berdeaux, A Roche, T Labaille, B Giroux, A Edouard, J F Giudicelli.   

Abstract

The hepatic extraction of amiodarone and N-desethylamiodarone has been investigated in seven patients following catheterization of the portal and hepatic veins under general anaesthesia. Amiodarone (600 mg) was administered orally 4 h before regional blood sampling. Concentrations of amiodarone and N-desethylamiodarone, determined by h.p.l.c., were about twice as high in the portal vein compared with those in the hepatic vein, the calculated hepatic extraction ratios of both compounds being 0.39 +/- 0.07 and 0.34 +/- 0.03, respectively. The presence of N-desethylamiodarone in the portal vein in higher concentrations than in the hepatic vein strongly suggests that N-dealkylation of amiodarone occurs in the gut wall or lumen, a finding which might account for the low and highly variable intersubject amiodarone bioavailability.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6508984      PMCID: PMC1463555          DOI: 10.1111/j.1365-2125.1984.tb02539.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  10 in total

1.  Selective vein catheterization for hormone assay in endocrine tumours of the pancreas. Technique and results.

Authors:  W Reichardt; S Ingemansson
Journal:  Acta Radiol Diagn (Stockh)       Date:  1980

2.  Bioavailability of amiodarone.

Authors:  G T Tucker; P R Jackson; G C Storey; D W Holt
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

3.  Amiodarone distribution in human tissues after sudden death during Holter recording.

Authors:  A P Maggioni; A Maggi; A Volpi; V D'Aranno; G Tognoni; P Giani
Journal:  Am J Cardiol       Date:  1983-07       Impact factor: 2.778

4.  Methods of the assessment of the effect of drugs on liver blood flow in man.

Authors:  E E Ohnhaus
Journal:  Br J Clin Pharmacol       Date:  1979-03       Impact factor: 4.335

5.  Rapid high-performance liquid chromatographic method for the measurement of amiodarone in blood plasma or serum at the concentrations attained during therapy.

Authors:  R J Flanagan; G C Storey; D W Holt
Journal:  J Chromatogr       Date:  1980-01-18

6.  Metabolism of flurazepam by the small intestine.

Authors:  W A Mahon; T Inaba; R M Stone
Journal:  Clin Pharmacol Ther       Date:  1977-08       Impact factor: 6.875

7.  Pancreatic venous sampling and arteriography in localizing insulinomas and gastrinomas: procedure and results in 55 cases.

Authors:  A Roche; A Raisonnier; M C Gillon-Savouret
Journal:  Radiology       Date:  1982-12       Impact factor: 11.105

8.  Amiodarone pharmacokinetics.

Authors:  D W Holt; G T Tucker; P R Jackson; G C Storey
Journal:  Am Heart J       Date:  1983-10       Impact factor: 4.749

9.  Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias.

Authors:  C I Haffajee; J C Love; A T Canada; L J Lesko; G Asdourian; J S Alpert
Journal:  Circulation       Date:  1983-06       Impact factor: 29.690

10.  Intestinal absorption, demethylation, and enterohepatic circulation of imipramine.

Authors:  H Dencker; S J Dencker; A Green; A Nagy
Journal:  Clin Pharmacol Ther       Date:  1976-05       Impact factor: 6.875

  10 in total
  2 in total

1.  The effects of plasmapheresis on thyroid hormone and plasma drug concentrations in amiodarone-induced thyrotoxicosis.

Authors:  B Uzzan; E Pussard; A Leon; D Bekhechi; A Krivitzky; E Modigliani; G Perret; R Vassy; A Berdeaux; J F Giudicelli
Journal:  Br J Clin Pharmacol       Date:  1991-03       Impact factor: 4.335

Review 2.  Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias.

Authors:  J Gill; R C Heel; A Fitton
Journal:  Drugs       Date:  1992-01       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.